These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
520 related articles for article (PubMed ID: 10871866)
1. Multiple endocrine neoplasia type 2B mutation in human RET oncogene induces medullary thyroid carcinoma in transgenic mice. Acton DS; Velthuyzen D; Lips CJ; Höppener JW Oncogene; 2000 Jun; 19(27):3121-5. PubMed ID: 10871866 [TBL] [Abstract][Full Text] [Related]
2. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393 [TBL] [Abstract][Full Text] [Related]
3. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas. Komminoth P Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671 [TBL] [Abstract][Full Text] [Related]
4. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)". Fink M; Weinhüsel A; Niederle B; Haas OA Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874 [TBL] [Abstract][Full Text] [Related]
5. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127 [TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma. Shirahama S; Ogura K; Takami H; Ito K; Tohsen T; Miyauchi A; Nakamura Y J Hum Genet; 1998; 43(2):101-6. PubMed ID: 9621513 [TBL] [Abstract][Full Text] [Related]
7. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan. Kameyama K; Okinaga H; Takami H Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413 [TBL] [Abstract][Full Text] [Related]
8. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866 [TBL] [Abstract][Full Text] [Related]
9. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218 [TBL] [Abstract][Full Text] [Related]
10. RET activation by germline MEN2A and MEN2B mutations. Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194 [TBL] [Abstract][Full Text] [Related]
11. De novo RET proto-oncogene mutation in a patient with multiple endocrine neoplasia type 2B. Chang TJ; Wu SL; Chang TC; Huang SH; Chang TJ J Formos Med Assoc; 1999 Oct; 98(10):692-7. PubMed ID: 10575840 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations. Kambouris M; Jackson CE; Feldman GL Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338 [TBL] [Abstract][Full Text] [Related]
13. Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. Salvatore D; Melillo RM; Monaco C; Visconti R; Fenzi G; Vecchio G; Fusco A; Santoro M Cancer Res; 2001 Feb; 61(4):1426-31. PubMed ID: 11245446 [TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A. Landsvater RM; Jansen RP; Hofstra RM; Buys CH; Lips CJ; Ploos van Amstel HK Hum Genet; 1996 Jan; 97(1):11-4. PubMed ID: 8557249 [TBL] [Abstract][Full Text] [Related]
15. RET oncogene mutations in medullary thyroid carcinoma in Mexican families. González B; Salcedo M; Medrano ME; Mantilla A; Quiñónez G; Benítez-Bribiesca L; Rodríguez-Cuevas S; Cabrera L; de León B; Altamirano N; Tapia J; Dawson B Arch Med Res; 2003; 34(1):41-9. PubMed ID: 12604374 [TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domain. Bugalho MJ; Frade JP; Santos JR; Limbert E; Sobrinho L Eur J Endocrinol; 1997 Apr; 136(4):423-6. PubMed ID: 9150704 [TBL] [Abstract][Full Text] [Related]
17. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Eng C; Smith DP; Mulligan LM; Healey CS; Zvelebil MJ; Stonehouse TJ; Ponder MA; Jackson CE; Waterfield MD; Ponder BA Oncogene; 1995 Feb; 10(3):509-13. PubMed ID: 7845675 [TBL] [Abstract][Full Text] [Related]
18. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers]. Sansó G; Domené HM; Iorcansky S; Barontini M Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252 [TBL] [Abstract][Full Text] [Related]
19. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Marsh DJ; Mulligan LM; Eng C Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949 [TBL] [Abstract][Full Text] [Related]
20. Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation. Iwashita T; Asai N; Murakami H; Matsuyama M; Takahashi M Oncogene; 1996 Feb; 12(3):481-7. PubMed ID: 8637703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]